Humacyte Inc.

NASDAQ: HUMA · Real-Time Price · USD
2.00
0.12 (6.38%)
At close: Aug 15, 2025, 12:51 PM

Humacyte Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a 1.56M 1.26M
Cost of Revenue
7.19M 76.55M 8.26M 61.34M
Gross Profit
-7.19M -76.55M -6.69M -60.08M
Operating Income
-114.4M -100.05M -84.58M -81.21M
Interest Income
4.1M 5.47M 2.63M 16K
Pretax Income
-148.7M -110.78M -11.96M -26.48M
Net Income
-148.7M -110.78M -11.96M -26.48M
Selling & General & Admin
25.8M 20.39M 22.88M 21.13M
Research & Development
88.6M 76.55M 63.26M 61.34M
Other Expenses
-7.19M -73.44M -8.26M -61.34M
Operating Expenses
107.21M 23.5M 77.89M 21.13M
Interest Expense
9.28M 6.6M 6.2M 4.35M
Selling & Marketing Expenses
n/a -3M n/a n/a
Cost & Expenses
114.4M 100.05M 86.14M 82.47M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
118.48M 103.42M 103.05M 39.97M
Shares Outstanding (Diluted)
118.48M 103.42M 103.05M 39.97M
EPS (Basic)
-1.26 -1.07 -0.12 -0.66
EPS (Diluted)
-1.26 -1.07 -0.12 -0.66
EBITDA
-132.23M -96.46M -76.37M -72.97M
EBIT
-139.42M -104.18M -84.58M -81.21M
Depreciation & Amortization
7.19M 7.72M 8.21M 8.28M